TG Therapeutics shares soared Wednesday after sales of its multiple sclerosis treatment met expectations. TGTX stock topped its 200-day line.

The post TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? appeared first on Investor’s Business Daily.